julio@aexcap.com
Worked for the last 37 years for large and small pharmaceutical/biotechnology companies conducting and managing upstream, downstream and analytical efforts while developing innovative technologies. Provided for the last 29 years biopharmaceutical, biochemistry, bioprocessing and agricultural biotechnology courses and workshops at leading universities (Washington University STL, Northwestern University, Stanford University, UC Santa Cruz, UC Davis, UC Berkeley, UC San Diego) and international conferences (Quebec, London, Berlin, Barcelona, Singapore, Lisbon, Amsterdam, Dusseldorf, Mexico City, Merida, San Luis Potosi and Vienna).
sweta@aexcap.com
Shweta has 7+ years of experience in the industry. Shweta is the Lead Clinical Program Manager. She had earlier worked with Cipla BioTec, where she managed End to End Phase I/III trial for biosimilar which was successfully completed in Australia and New Zealand, India, South Africa, Hungary and Bulgaria.
She has experience in CRO negotiation, Site management (oversight), Site audit, IVRS, IP management through vendors.
keval@aexcap.com
Keval has over 7 years of industry experience spanning across corporate strategy, operations, new process set-up, new product launches, corporate finance, fund raising and commercial deals. He has been instrumental in developing disruptive, competitive and sustainable business model for Cipla BioTec. He prepared and successfully controlled annual development budget for Cipla BioTec. He understands the nuances of biopharma manufacturing and has spearheaded commercial discussions with top suppliers of biopharma equipment, media and feed during his stint at Cipla BioTec.
Page 2 of 2